'Get down Shep!'!Blue Peter kids from the 70's...

'Get down Shep!'!
Blue Peter kids from the 70's will get this.

It's beginning - 'Valley of the Trolls' (geez becoming cryptic as Snowy).

As Immutep becomes more successful and meet/exceed data expectations, new posters will miraculously appear with 'sage advice' and quote mysterious historical SP events.
Their (or whoever funds their BS) game plan is to put fear and doubt into Immutep SH's (or would be SH's).
This strategy is common practise amongst small cap ASX listed companies.
Its actually a sign that big players are at the gate and have started to send out their 'dogs' to sniff out or try to change sentiment on forums like HC.
Why - because they want to accumulate shares
at lowest possible price.
Personally I believe the watershed moment of our future success and market cap rerating is very close.
ASCO - imminent
Followed soon after by 'business development update' webcast - which must be related to ASCO data results- otherwise why not release pre-ASCO?
Speculation (over a rather good Pinot noir).
BMS - licensing agreement or ?
Merck - licensing agreement or ?
Either of above could benefit from efti and combo efficacy/ safety with their blockbuster PD 1 drugs - plus increase patent life of 'Keytruda/Opdivo' in many cancer 'first line' settings.
Pfizer - dark horse - cashed up - see 'Insight'

Obviously data from TACTI and AIPAC needs to be consistent and hopefully improve OS.

Without getting to melodramatic, IMO it's Immutep's time to shine on the oncology big stage with LAG-3

Efti - next immune checkpoint inhibitor!